Eledon Pharmaceuticals, Inc. Shareholders' Equity
Eledon Pharmaceuticals, Inc. (ELDN) had Shareholders' Equity of $33.01 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $33.01M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $44.76M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $81.08M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $35.36M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $33.01M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $44.76M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $81.08M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $35.36M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $50.33M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $58.89M 10-Q · filed 2026-08-13 | $114.58M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $62.45M 10-Q · filed 2026-08-13 | $118.14M 10-K · filed 2025-03-20 |
| 2024-09-30 | $20.36M 10-Q · filed 2025-11-14 | $76.06M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$64.19M 10-Q · filed 2025-11-14 | -$8.50M 10-Q · filed 2024-08-19 |
| 2024-03-31 | -$70.42M 10-Q · filed 2025-11-14 | $74.82M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$48.49M 10-K · filed 2026-03-19 | $83.42M 10-K · filed 2024-03-28 |
| 2023-09-30 | $35.60M 10-Q · filed 2024-11-12 | $91.33M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $43.77M 10-Q · filed 2024-11-12 | $99.95M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $74.79M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $23.79M 10-K/A · filed 2025-08-14 | $84.18M 10-K · filed 2023-03-30 |
| 2022-09-30 | $141.09M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $149.38M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $156.32M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $164.00M 10-K/A · filed 2024-08-19 | |
| 2021-09-30 | $170.75M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $178.52M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $183.87M 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $190.60M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $21.51M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $9.36M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $11.74M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $9.46M 10-K · filed 2022-03-24 | |
| 2019-09-30 | $13.37M 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $16.03M 10-Q · filed 2020-11-16 | |
| 2019-03-31 | $9.93M 10-Q · filed 2020-08-14 | |
| 2018-12-31 | $14.49M 10-K · filed 2021-03-31 | |
| 2018-09-30 | $18.32M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $21.51M 10-Q · filed 2019-11-13 | |
| 2018-03-31 | $24.30M 10-Q · filed 2019-08-13 | |
| 2017-12-31 | $19.45M 10-K · filed 2020-03-17 | |
| 2017-09-30 | $20.62M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $23.44M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $23.36M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | -$2.70M 10-K · filed 2019-03-28 | $26.86M 10-K · filed 2017-03-03 |
| 2016-09-30 | $30.26M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $38.88M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $51.41M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $2.78M 10-K · filed 2018-04-02 | $61.72M 10-K · filed 2016-03-10 |
| 2015-09-30 | $71.90M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $82.75M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $90.90M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $103.50M 10-K · filed 2017-03-03 | |
| 2014-09-30 | $101.61M 10-Q · filed 2014-11-13 | |
| 2013-12-31 | -$55.27M 10-K · filed 2017-03-03 | |
| 2012-12-31 | -$39.90M 10-K · filed 2016-03-10 | |
| 2011-12-31 | -$30.43M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |